Hyperion DeFi, Inc. (HYPD) Stock

NASDAQ: HYPDHealthcare company in the biotechnology industry, based in Dallas, TX.

Hyperion DeFi stock price chart

HYPD interactive chart →

HYPD stock quote & key statistics

Hyperion DeFi earnings per share

Income →
Earnings per share

Hyperion DeFi revenue & net income

Income →
RevenueNet income

Hyperion DeFi annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$813,455-$45.3M-$10.33
FY2024$57,336-$49.8M-$54.75
FY2023$3,787-$27.3M-$27.53
FY2022$0-$28.0M-$48.24
FY2021$14.0M-$12.8M-$42.52

Fiscal year ending December 31. Source: company filings via EODHD.

About Hyperion DeFi, Inc.

Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products.

The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.

Hyperion DeFi stock FAQ

What is the Hyperion DeFi stock ticker symbol?

Hyperion DeFi, Inc. trades on the NASDAQ under the ticker symbol HYPD.

What sector and industry is Hyperion DeFi in?

Hyperion DeFi, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Hyperion DeFi have?

Hyperion DeFi, Inc. has about 9 full-time employees.

What were Hyperion DeFi's revenue and earnings last fiscal year?

Hyperion DeFi reported revenue of $813,455 and net income of -$45.3M in fiscal 2025, with earnings per share of -$10.33. Revenue grew 1318.8% from the prior year.

When did Hyperion DeFi go public?

Hyperion DeFi stock began trading on January 25, 2018.

Biotechnology stocks

All Healthcare stocks →